811PAssociation of grade ≥3 neutropenia (NP) with outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving cabazitaxel. (23rd October 2018) - Meisel, A; de Wit, R; Oudard, S; Sartor, O; Stenner-Liewen, F; Shun, Z; Ozatilgan, A; Eisenberger, M; de Bono, J S